Neosync ranked #30 Holder of Pervasive Neurotech Intellectual Property*

By SharpBrains | August 19, 2015 |

Neo­sync is an ear­ly stage com­pa­ny devel­op­ing a new treat­ment  for major depres­sion based on Tran­scra­nial Mag­net­ic Stim­u­la­tion (TMS). The treatment–named NEST (Neo­sync EEG Syn­chro­nized TMS) and under­go­ing clin­i­cal trials–is based on the idea that depres­sion patients tend to have over­ly rhyth­mic brain activity, 

Read More

Brainlab ranked #5 Holder of Pervasive Neurotech Intellectual Property*

By SharpBrains | June 1, 2015

Brain­lab is a Ger­man health­care inno­va­tion com­pa­ny that devel­ops a wide array of tech­nolo­gies for the plan­ning and guid­ance of surgery and radio­surgery.  Such prod­ucts are designed to con­tin­u­ous­ly track sur­gi­cal instru­ments in rela­tion to anatom­i­cal ori­en­ta­tion in order to pro­vide sur­geons the tools need­ed to com­plete a rou­tine or com­plex pro­ce­dure.  Their pri­ma­ry product…

Read More

Non-invasive brain stimulation meets nanotechnology

By SharpBrains | March 19, 2015

. MIT Researchers Devel­op Wire­less, Non­in­va­sive Deep Brain Stim­u­la­tion Approach (Med Device online): “Sci­en­tists have intro­duced a nov­el method of admin­is­ter­ing brain stim­u­la­tion that requires no implants or exter­nal con­nec­tions. By inject­ing mag­net­ic nanopar­ti­cles into the brain, researchers have found that they can manip­u­late neu­rons by apply­ing exter­nal mag­net­ic fields

Read More

Good survey of brain stimulation methods, value and limitations

By SharpBrains | May 31, 2013

Stim­u­lat­ing the Brain: From If to How (The Dana Foun­da­tion): “Recent years have brought mod­ern meth­ods of brain stim­u­la­tion into the main­stream of neu­rol­o­gy and psy­chi­a­try. But their mechanism—how exact­ly deep brain stim­u­la­tion (DBS) relieves Parkinson’s dis­ease symp­toms and how repet­i­tive tran­scra­nial mag­net­ic stim­u­la­tion (rTMS) improves depres­sion, for example—remains obscure. Research

Read More